Sun Pharma signs MFN pricing deal with US government to extend affordable medicines to Medicaid programmes. Mumbai drugmaker to apply Most Favoured Nation pricing to future innovative launches. US delays Section 232 tariffs by 2 years.
Amid increased tariffs, Sun Pharma to invest, set up plant in US, signs deal
- Post author:pracheeshofficial@gmail.com
- Post published:02/09/2026
- Post category:DAILY UPDATES
- Post comments:0 Comments